Published 19:35 IST, January 7th 2021
COVID-19: CureVac, Bayer ink agreement to produce 'hundreds of doses' of vaccine
German pharmaceutical firms Bayer and CureVac on January 6 said that they have joined forces in the development of CureVac's Covid-19 vaccine candidate.
null | Image:
self
Advertisement
19:35 IST, January 7th 2021